Xiangang Zeng

Title: Xiangang Zeng: Innovator in Metabolic Disease Treatment

Introduction

Xiangang Zeng is a prominent inventor based in Princeton, NJ (US). He has made significant contributions to the field of metabolic diseases and cancer treatment through his innovative research and patents. His work focuses on mitochondrial uncouplers, which have the potential to revolutionize therapeutic approaches in these areas.

Latest Patents

Xiangang Zeng holds a patent for "Mitochondrial uncouplers for treatment of metabolic diseases and cancer - 2-hydroxy-benzoic anilide compounds and derivatives, compositions thereof, and methods for treating metabolic diseases and cancer through uncoupling mitochondria." This patent highlights his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Zeng is affiliated with Rutgers, the State University of New Jersey, where he conducts his research. His work has garnered attention for its innovative approach to addressing complex health issues. With a focus on mitochondrial function, Zeng's research aims to provide new avenues for treatment.

Collaborations

Xiangang Zeng collaborates with esteemed colleagues, including Shengkan Jin and David John Augeri. These partnerships enhance the scope and impact of his research, fostering a collaborative environment that drives innovation.

Conclusion

Xiangang Zeng is a dedicated inventor whose work in mitochondrial uncouplers holds promise for the treatment of metabolic diseases and cancer. His contributions to the field are noteworthy, and his collaborations further amplify the potential impact of his research.